Combination Treatment Regimens - SMARCA2 Degrader With Gemcitabine

Number of patents in Portfolio can not be more than 2000

United States of America

APP PUB NO 20250114353A1
SERIAL NO

18906330

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed are methods of treating cancer comprising administering to a subject a treatment regimen comprising a compound of Formula (I):

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
PRELUDE THERAPEUTICS INCORPORATED200 POWDER MILL ROAD EXPERMENTAL STATEION E400/3213 WILMINGTON DE 19803

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Hulse, Michael Doylestown, US 22 70
Ito, Koichi Philadelphia, US 310 4641
Scherle, Peggy Wayne, US 2 0
Vaddi, Krishna Chadds Ford, US 28 1391

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation